SCHEMBL10176156

SCHEMBL10176156

Cc1cc(OCCN2CCN(C)CC2)ccc1N

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HRH3 Q9Y5N1 4/20 0.52
DRD3 P35462 1/20 0.52
LTA4H P09960 1/20 0.52
NPC1 O15118 2/20 0.52
SIGMAR1 Q99720 1/20 0.50
USP2 O75604 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 2/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAOB P27338 1/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12005974 0.93 HRH3 (0.62) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL14100107 0.88 KDM4E (0.64) MEN1KMT2AKDM4EHRH3LTA4H
SCHEMBL214568 0.88 MEN1 (0.57) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL23640213 0.86 MEN1 (0.58) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL2946059 0.86 NPC1 (0.71) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL6035058 0.85 MEN1 (0.55) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL10360467 0.83 HRH3 (0.50) MEN1KMT2AKDM4EHRH3LTA4H
SCHEMBL2204177 0.83 MEN1 (0.52) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL14419243 0.82 KDM4E (0.59) MEN1KMT2AKDM4EALDH1A1HRH3
SCHEMBL16815651 0.82 MEN1 (0.55) MEN1KMT2AKDM4EALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE48140-E1 Furanone derivative CARNA BIOSCIENCES, INC. (JP) 2020-08-04 US disclosed
EP-2692728-B1 NOVEL FURANONE DERIVATIVE CARNA BIOSCIENCES INC (JP) 2018-07-04 EP disclosed
US-RE46815-E1 Furanone derivative CARNA BIOSCIENCES, INC. (JP) 2018-05-01 US disclosed
US-8742113-B2 Furanone derivative SBI BIOTECH CO., LTD. (JP) 2014-06-03 US disclosed
EP-2692728-A1 NOVEL FURANONE DERIVATIVE SBI Biotech Co., Ltd. (JP) 2014-02-05 EP disclosed
US-20140018533-A1 NOVEL FURANONE DERIVATIVE CARNA BIOSCIENCES, INC. (JP) 2014-01-16 US disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
WO-2010122979-A1 THIAZOLIDINONE DERIVATIVE SBIバイオテック株式会社 (JP) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 MEN1 1406/4885KMT2A 3437/4885KDM4E 2805/4885
US-20140018533-A1 NOVEL FURANONE DERIVATIVE CYP11B1, OXER1, CYP11B2 MEN1 427/4885KMT2A 3897/4885KDM4E 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.